Pyridylmethylthio derivatives as VEGF inhibitors: Part 2

Optimization of compounds 5 and 6 led to the discovery of VEGF inhibitor 10g which reduced CYP inhibition. It was highly active in vitro (VEGF induced HUVEC proliferation assay) and showed efficacies in three disease models in vivo (cancer, RA, and AMD).

Figure optionsDownload as PowerPoint slide